Biocomposites year of international growth and product advancement
Expansion into new geographies and enhanced approval for STIMULAN to treat bacterial infection
Keele, UK, 15 December 2021 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is pleased to provide the following business update.
